| Title: | Blocking AMPK?1 myristoylation enhances AMPK activity and protects mice from high-fat diet-induced obesity and hepatic steatosis |
| Authors: | Neopane, K Kozlov, N Negoita, F Murray-Segal, L Brink, R Hoque, A Ovens, AJ Tjin, G McAloon, LM Yu, DY Ling, NXY Sanders, MJ Oakhill, JS Scott, JW Steinberg, GR Loh, K Kemp, BE Sakamoto, K Galic, S |
| Issue Year: | 2022 |
| Publisher | CELL PRESS |
| Series | CELL REPORTS: |
| Abstract | AMP-activated protein kinase (AMPK) is a master regulator of cellular energy homeostasis and a therapeutic target for metabolic diseases. Co/post-translational N-myristoylation of glycine-2 (Gly2) of the AMPK 0 subunit has been suggested to regulate the distribution of the kinase between the cytosol and membranes through a myristoyl switchmechanism. However, the relevance of AMPK myristoylation for metabolic signaling in cells and in vivo is unclear. Here, we generated knockin mice with a Gly2-to-alanine point mutation of AMPK01 (01-G2A). We demonstrate that non-myristoylated AMPK01 has reduced stability but is associated with increased kinase activity and phosphorylation of the Thr172 activation site in the AMPK a subunit. Using proximity ligation assays, we show that loss of 01 myristoylation impedes colocalization of the phosphatase PPM1A/B with AMPK in cells. Mice carrying the 01-G2A mutation have improved metabolic health with reduced adiposity, hepatic lipid accumulation, and insulin resistance under conditions of high-fat diet-induced obesity. |
| URI: | https://publications.svi.edu.au/publications/8890 |
| Other Identifiers | 10.1016/j.celrep.2022.111862 |
| Publication type | Article |